Delirium in Critically Ill Cancer Patients With COVID-19.

ABSTRACT:

Background

COVID-19 has been a devastating pandemic with little known of its neuropsychiatric complications. Delirium is 1 of the most common neuropsychiatric syndromes among hospitalized cancer patients with incidence ranging from 25% to 40% and rates of up to 85% in the terminally ill. Data on the incidence, risk factors, duration, and outcomes of delirium in critically ill cancer patients with COVID-19 are lacking.

Objective

To report the incidence, riaks and outcomes of critically ill cancer patients who developed COVID-19.

Methods

This is a retrospective single-center study evaluating delirium frequency and outcomes in all critically ill cancer patients with COVID-19 admitted between March 1 and July 10, 2020. Delirium was assessed by Confusion Assessment Method

SUBMITTER: Bjerre Real C 

PROVIDER: S-EPMC9162788 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature